Prevalence
Causes
Clinical
features
Investigations
Therapy
Prevention
Prognosis
|  |  | | Therapy |
Malignancy
Give pamidronate
a 90 mg
over 1 hour intravenously
a
Why?
-
It speeds return to
normocalcaemia
and reduces relapse
a
-
Fever is a common side-effect
a
-
90 mg of pamidronate is more effective than 30 or 60 mg
a
-
It is more effective than etidronate
a
,
clondronate, and mithramycin
a
and the effects lasts longer (on average 2 weeks
a
90 mg of pamidronate helps correct
hypercalcaemia
and prevents relapse
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
hypercalcaemia
a
|
pamidronate
|
placebo
|
normocalcaemia
at
7
days
|
22%
|
-220%
(-611% to
-44%)
|
2
(1 to
4)
|
|
|
|
|
fever due to medication
at
7
days
|
0.0%
|
|
-5
(-10 to
-3)
|
|
|
|
|
relapse (following
normocalcaemia
)
at
7
days
|
91%
|
43%
(23% to
58%)
|
3
(2 to
5)
|
hypercalcaemia
a
|
pamidronate 90 mg iv
|
pamidronate 60 mg iv
|
normocalcaemia
|
100%
|
-64%
(-137% to
-13%)
|
3
(2 to
6)
|
hypercalcaemia
a
|
pamidronate
|
etidronate
|
normocalcaemia
at
7
days
|
40%
|
-75%
(-180% to
-10%)
|
3
(2 to
14)
|
hypercalcaemia
a
|
pamidronate
|
clondronate
|
normocalcaemia
at
7
days
|
80%
|
-25%
(-56% to
0%)
|
5
(3 to
40)
|
hypercalcaemia
a
|
pamidronate
|
mithramycin
|
normocalcaemia
at
9
days
|
86%
|
-270%
(-860% to
-40%)
|
1
(1 to
2)
|
|